The Sri Lanka Journal of Surgery

该期刊要求作者资格严格遵循ICMJE的建议：对工作的构思或设计有实质性贡献，或负责数据的获取、分析或解释；起草工作或对工作内容进行重要的批判性修改；对拟发表版本进行最终批准；并同意对工作的所有方面负责，确保与工作任何部分的准确性或完整性相关的问题得到适当调查和解决。 模型中文摘要

The recommendations of the ICMJE regarding authorship should be strictly adhered to. They are: Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND Drafting the work or revising it critically for important intellectual content; AND Final approval of the version to be published; AND Agreement to be accountable f…

该期刊要求作者声明任何竞争利益，以便编辑对稿件做出最佳决定。竞争利益几乎不可避免，期刊不会仅因作者存在竞争利益而拒稿，但竞争利益将在已发表的论文上予以声明。当专业判断（如患者福利或研究的有效性）可能受次要利益（如经济利益或个人关系）影响时，即存在竞争利益。 模型中文摘要

To make the best decision on how to deal with a manuscript the journal editor should know about any competing interests that authors may have. We are not aiming to eradicate competing interests as they are almost inevitable. We will not reject papers simply because authors have a competing interest, but these will be declared on the published paper. A competing interest exists when professional ju…

该期刊鼓励原创研究文章的作者在投稿时附上数据共享声明，说明研究中哪些额外的未发表数据可用，以及如何获取这些数据。 模型中文摘要

Authors of original research articles are encouraged to include a data sharing statement when submitting their article. The statement should explain which additional unpublished data from the study is available, and how these can be obtained.

该期刊遵循出版伦理委员会（COPE）所描绘的出版伦理，是该组织的成员，并被列为遵循ICMJE关于医学期刊学术工作的行为、报告、编辑和出版建议的期刊。 模型中文摘要

The journal adheres to the publication ethics as portrayed by the Committee on Publication Ethics (COPE) and is a member of this organisation. It is listed as an ICMJE journal which follow its recommendations (ICMJE recommendations) on Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals.

该期刊允许作者（或其雇主）保留其作品的版权，仅要求获得允许其在期刊上发表文章并转授权及利用所有附属权利的独家许可。通讯作者应在投稿时代表所有作者发送声明，授予该期刊及其被许可人在全球范围内的独家许可，允许文章（如被接受）在该期刊发表并利用所有附属权利。 模型中文摘要

The SLJS allows authors (or their employers) to retain their copyright in their work. SLJS only requires an exclusive licence that allows us to publish the article in the journal and allows us to sub-licence such rights and exploit all subsidiary rights. The corresponding author should on behalf of all authors send the following statement at the point of submission: "The Corresponding Author has t…

该期刊目前为开放获取期刊，不向作者收取任何费用。 模型中文摘要

The SLJS is currently an open access journal. No fees are levied from authors for this service.

该期刊所有投稿的稿件均需经过内部和/或外部评审。期刊编辑团队撰写的原创研究文章将进行独立同行评审，编辑对其自己的文章在同行评审过程或出版决定上没有任何输入或影响；编辑撰写的社论和讣告不进行外部同行评审。投稿稿件首先由编辑/编辑委员会进行初步评审，如被认为值得考虑发表，将分配给内部和外部评审。 模型中文摘要

All manuscripts submitted to the SLJS undergo a review, internally and/or externally. Original research articles authored by a member of a journal’s editorial team are independently peer reviewed; an editor will have no input or influence on the peer review process or publication decision for their own article. Editorials and obituaries written by the journal’s editor do not undergo external peer …

该期刊所有被接受发表的材料在在线发表前均处于禁发状态，在此之前不得分发给第三方或与媒体讨论，但作为禁发新闻稿的一部分分发给记者的研究除外（由该期刊发布或与该期刊协商发布）。 模型中文摘要

All material accepted for publication in the SLJS is under embargo until it is published online. This means that until then it shouldn't be distributed to third parties or discussed with the media, with the exception of research distributed to journalists as part of an embargoed press release (either issued by SLJS or in consultation with SLJS).

该期刊根据ICMJE建议，要求所有临床试验报告在稿件来源国的临床试验注册机构进行前瞻性注册。自2008年7月1日起，符合条件的试验被ICMJE定义为“人类参与者被前瞻性分配到一个或多个健康相关干预措施（包括健康服务和行为干预）以评估对健康结果影响的试验”，在此之前定义更为狭窄。 模型中文摘要

In accordance with the ICMJE Recommendations, all reports of clinical trials should be prospectively registered with the clinical trial registry of the country of origin of the manuscript. Eligible trials have been defined by ICMJE since 1 July 2008 as “where human participants are prospectively assigned to one or more health-related interventions [including health services and behavioural interve…